These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 5513037)

  • 21. Effect of gamma-hydroxybutyrate and gamma-butyrolactone on dopamine synthesis and uptake by rat striatum.
    Bustos G; Kuhar MJ; Roth RH
    Biochem Pharmacol; 1972 Oct; 21(19):2649-52. PubMed ID: 4661622
    [No Abstract]   [Full Text] [Related]  

  • 22. Increase in brain dopamine after axotomy or treatment with gammahydroxybutyric acid due to elimination of the nerve impulse flow.
    Stock G; Magnusson T; Andén NE
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 278(4):347-61. PubMed ID: 4269968
    [No Abstract]   [Full Text] [Related]  

  • 23. Shock-induced aggression: effects of 6-hydroxydopamine and other pharmacological agents.
    Thoa NB; Eichelman B; Ng LK
    Brain Res; 1972 Aug; 43(2):467-75. PubMed ID: 5066136
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of L-dopa on accumulation and efflux of monoamines in particles of rat brain homogenates.
    Ng LK; Colburn RW; Kopin IJ
    J Pharmacol Exp Ther; 1972 Nov; 183(2):316-25. PubMed ID: 5083548
    [No Abstract]   [Full Text] [Related]  

  • 25. Acceleration of turnover of 14C-catecholamines in rat brain by chlorpromazine.
    Gey KF; Pletscher A
    Experientia; 1968 Apr; 24(4):335-6. PubMed ID: 5705176
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of dihydroxyphenylalanine, pheniprazine and dextroamphetamine on the in vivo release of dopamine from the caudate nucleus.
    McKenzie GM; Szerb JC
    J Pharmacol Exp Ther; 1968 Aug; 162(2):302-8. PubMed ID: 4385909
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of some psychotropic drugs on dopamine synthesis in the rat striatum.
    Besson MJ; Cheramy A; Glowinski J
    J Pharmacol Exp Ther; 1971 Apr; 177(1):196-205. PubMed ID: 4398047
    [No Abstract]   [Full Text] [Related]  

  • 28. Neuropsychopharmacology of monoamines and their regulatory enzymes.
    Lipton MA
    Adv Biochem Psychopharmacol; 1974; 12(0):443-54. PubMed ID: 4153941
    [No Abstract]   [Full Text] [Related]  

  • 29. Dopaminergic neurons: similar biochemical and histochemical effects of gamma-hydroxybutyrate and acute lesions of the nigro-neostriatal pathway.
    Walters JR; Roth RH; Aghajanian GK
    J Pharmacol Exp Ther; 1973 Sep; 186(3):630-9. PubMed ID: 4728341
    [No Abstract]   [Full Text] [Related]  

  • 30. [Variations of cerebral biogenic amines after injection of 4-butyrolactone].
    Nouaille-Degorce J; Riotte M; Barras B; Pegon Y; Cier A
    C R Seances Soc Biol Fil; 1971; 165(7):1676-81. PubMed ID: 4261929
    [No Abstract]   [Full Text] [Related]  

  • 31. Aggression in mice associated with changes in the monoamine metabolism of the brain.
    Lycke E; Modigh K; Roos BE
    Experientia; 1969 Sep; 25(9):951-3. PubMed ID: 5392704
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effects of the injection of gamma-hydroxybutyrate of Na and of gamma-butyrrolactone into different zones of the brain and into the cerebrospinal fluid system. II. Influence on the cerebral dopamine content in the rabbit].
    Gessa LG; Vargiu L; Crabai F; Bezzi G; Camba R
    Boll Soc Ital Biol Sper; 1967 Mar; 43(6):287-8. PubMed ID: 6056643
    [No Abstract]   [Full Text] [Related]  

  • 33. L-dopa in Parkinsonism. A possible mechanism of action.
    Ng LK; Chase TN; Colburn RW; Kopin IJ
    Neurology; 1972 Jul; 22(7):688-96. PubMed ID: 4673250
    [No Abstract]   [Full Text] [Related]  

  • 34. [Influences of hypnotics (especially nitrazepam, -hydroxybutyric acid) on sleep-wakefulness mechanisms in cats].
    Takeshima T
    Seishin Shinkeigaku Zasshi; 1971 Jun; 73(6):495-532. PubMed ID: 4328480
    [No Abstract]   [Full Text] [Related]  

  • 35. Enhancement of tyrosine transamination in vivo by catecholamines.
    Bartholini G; Gey KF; Pletscher A
    Experientia; 1970 Sep; 26(9):980-1. PubMed ID: 4394629
    [No Abstract]   [Full Text] [Related]  

  • 36. The monoamine metabolism in viral encephalitides of the mouse. II. Turnover of monoamines in mice infected with herpes simplex virus.
    Lycke E; Roos BE
    Brain Res; 1972 Sep; 44(2):603-13. PubMed ID: 4342444
    [No Abstract]   [Full Text] [Related]  

  • 37. Biosynthesis of cerebral phenolic amines. I. In vivo formation of p-tyramine, octopamine, and synephrine.
    Boulton AA; Wu PH
    Can J Biochem; 1972 Mar; 50(3):261-7. PubMed ID: 4553609
    [No Abstract]   [Full Text] [Related]  

  • 38. Putative neurotransmitters in the brain: selective neuronal uptake, subcellular localization, and interactions with centrally acting drugs.
    Snyder SH
    Biol Psychiatry; 1970 Oct; 2(4):367-89. PubMed ID: 4320227
    [No Abstract]   [Full Text] [Related]  

  • 39. [Serotoninergic mechanism of dependence of neurotropic properties of lithium hydroxybutyrate on circadian phase of its administration].
    Zamoshchina TA; Saratikov AS; Fisanova LL
    Biull Eksp Biol Med; 1998 Apr; 125(4):413-6. PubMed ID: 9631724
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacokinetics and pharmacodynamics of gamma-hydroxybutyric acid during tolerance in rats: effects on extracellular dopamine.
    Raybon JJ; Boje KM
    J Pharmacol Exp Ther; 2007 Mar; 320(3):1252-60. PubMed ID: 17138862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.